Logo

Wilf Keller, Daniel Marshak

Jul 15, 2008
Premium
Wilf Keller has been appointed as president and CEO of Genome Prairie. Keller will assume the position starting October 1.
 
He joins Genome Prairie from the Plant Biotechnology Institute of the National Research Council of Canada in Saskatchewan.
 
 
PerkinElmer has named Daniel Marshak to be president of the company’s Greater China operations. Marshak will be based out of Shangai, and he will continue to serve in his current position as the company’s senior vice president and chief scientific officer.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.